Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico
Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children wi...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Norberto Sotelo [verfasserIn] Guillermo López [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2005 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Annals of Hepatology - Elsevier, 2021, 4(2005), 4, Seite 255-260 |
|---|---|
| Übergeordnetes Werk: |
volume:4 ; year:2005 ; number:4 ; pages:255-260 |
| Links: |
|---|
| DOI / URN: |
10.1016/S1665-2681(19)32048-4 |
|---|
| Katalog-ID: |
DOAJ05293960X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ05293960X | ||
| 003 | DE-627 | ||
| 005 | 20230308171617.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2005 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1665-2681(19)32048-4 |2 doi | |
| 035 | |a (DE-627)DOAJ05293960X | ||
| 035 | |a (DE-599)DOAJ99846554ce38411d82f9b5ca1a08b5b8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC581-951 | |
| 100 | 0 | |a Norberto Sotelo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico |
| 264 | 1 | |c 2005 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children with AI-CAH treated between 1978 and 2004 at the Hospital Infantil del Estado de Sonora in the Sonora State capital of Hermosillo in northern Mexico. Materials and methods: We conducted a retrospective review that included the following variables: age; sex; personal antecedents; signs and symptoms; laboratory and medical office studies; histologic tissue pattern obtained by biopsy; treatment; evolution, and mortality. Results: Thirteen males and 10 females participated in the study; predominant signs were hyporexia, fatigue-hepatomegalia, and icterus. Ten patients presented moderate anemia and six patients, leukopenia and thrombocytopenia. Eighteen patients presented hypergammaglobulinemia. Twenty three patients had percutaneous (p.c.) liver biopsy, and we observed the following histologic pattern: rupture of the limiting plate; necrotic foci; cholangiolar proliferation, and fibrotic bridges; in addition, four patients demonstrated precirrhotic changes. Twenty one children received prednisone for periods of between 1 and 12 years; in seven cases, children were administered azatioprine. Six children presented histologic, biochemical, and clinical remission, nine experienced biochemical remission but presented inflammatory activity, five abandoned treatment, and three died due to cirrhosis, liver insufficiency, and other complications. Discussion: To date, AI-CAH etiology continues to be unknown, while treatment has not been importantly modified in 50 years and continues to consist of prednisone alone or in association with azathioprine. | ||
| 650 | 4 | |a Autoimmune hepatitis | |
| 650 | 4 | |a autoimmune-type chronic active hepatitis | |
| 653 | 0 | |a Specialties of internal medicine | |
| 700 | 0 | |a Guillermo López |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Annals of Hepatology |d Elsevier, 2021 |g 4(2005), 4, Seite 255-260 |w (DE-627)DOAJ078617936 |x 26595982 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2005 |g number:4 |g pages:255-260 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S1665-2681(19)32048-4 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/99846554ce38411d82f9b5ca1a08b5b8 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1665268119320484 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1665-2681 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a GBV_ILN_2002 | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2005 |e 4 |h 255-260 | ||
| author_variant |
n s ns g l gl |
|---|---|
| matchkey_str |
article:26595982:2005----::uomueyehoiatvhpttsnhlrnrpro2cssths |
| hierarchy_sort_str |
2005 |
| callnumber-subject-code |
RC |
| publishDate |
2005 |
| allfields |
10.1016/S1665-2681(19)32048-4 doi (DE-627)DOAJ05293960X (DE-599)DOAJ99846554ce38411d82f9b5ca1a08b5b8 DE-627 ger DE-627 rakwb eng RC581-951 Norberto Sotelo verfasserin aut Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children with AI-CAH treated between 1978 and 2004 at the Hospital Infantil del Estado de Sonora in the Sonora State capital of Hermosillo in northern Mexico. Materials and methods: We conducted a retrospective review that included the following variables: age; sex; personal antecedents; signs and symptoms; laboratory and medical office studies; histologic tissue pattern obtained by biopsy; treatment; evolution, and mortality. Results: Thirteen males and 10 females participated in the study; predominant signs were hyporexia, fatigue-hepatomegalia, and icterus. Ten patients presented moderate anemia and six patients, leukopenia and thrombocytopenia. Eighteen patients presented hypergammaglobulinemia. Twenty three patients had percutaneous (p.c.) liver biopsy, and we observed the following histologic pattern: rupture of the limiting plate; necrotic foci; cholangiolar proliferation, and fibrotic bridges; in addition, four patients demonstrated precirrhotic changes. Twenty one children received prednisone for periods of between 1 and 12 years; in seven cases, children were administered azatioprine. Six children presented histologic, biochemical, and clinical remission, nine experienced biochemical remission but presented inflammatory activity, five abandoned treatment, and three died due to cirrhosis, liver insufficiency, and other complications. Discussion: To date, AI-CAH etiology continues to be unknown, while treatment has not been importantly modified in 50 years and continues to consist of prednisone alone or in association with azathioprine. Autoimmune hepatitis autoimmune-type chronic active hepatitis Specialties of internal medicine Guillermo López verfasserin aut In Annals of Hepatology Elsevier, 2021 4(2005), 4, Seite 255-260 (DE-627)DOAJ078617936 26595982 nnns volume:4 year:2005 number:4 pages:255-260 https://doi.org/10.1016/S1665-2681(19)32048-4 kostenfrei https://doaj.org/article/99846554ce38411d82f9b5ca1a08b5b8 kostenfrei http://www.sciencedirect.com/science/article/pii/S1665268119320484 kostenfrei https://doaj.org/toc/1665-2681 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 AR 4 2005 4 255-260 |
| spelling |
10.1016/S1665-2681(19)32048-4 doi (DE-627)DOAJ05293960X (DE-599)DOAJ99846554ce38411d82f9b5ca1a08b5b8 DE-627 ger DE-627 rakwb eng RC581-951 Norberto Sotelo verfasserin aut Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children with AI-CAH treated between 1978 and 2004 at the Hospital Infantil del Estado de Sonora in the Sonora State capital of Hermosillo in northern Mexico. Materials and methods: We conducted a retrospective review that included the following variables: age; sex; personal antecedents; signs and symptoms; laboratory and medical office studies; histologic tissue pattern obtained by biopsy; treatment; evolution, and mortality. Results: Thirteen males and 10 females participated in the study; predominant signs were hyporexia, fatigue-hepatomegalia, and icterus. Ten patients presented moderate anemia and six patients, leukopenia and thrombocytopenia. Eighteen patients presented hypergammaglobulinemia. Twenty three patients had percutaneous (p.c.) liver biopsy, and we observed the following histologic pattern: rupture of the limiting plate; necrotic foci; cholangiolar proliferation, and fibrotic bridges; in addition, four patients demonstrated precirrhotic changes. Twenty one children received prednisone for periods of between 1 and 12 years; in seven cases, children were administered azatioprine. Six children presented histologic, biochemical, and clinical remission, nine experienced biochemical remission but presented inflammatory activity, five abandoned treatment, and three died due to cirrhosis, liver insufficiency, and other complications. Discussion: To date, AI-CAH etiology continues to be unknown, while treatment has not been importantly modified in 50 years and continues to consist of prednisone alone or in association with azathioprine. Autoimmune hepatitis autoimmune-type chronic active hepatitis Specialties of internal medicine Guillermo López verfasserin aut In Annals of Hepatology Elsevier, 2021 4(2005), 4, Seite 255-260 (DE-627)DOAJ078617936 26595982 nnns volume:4 year:2005 number:4 pages:255-260 https://doi.org/10.1016/S1665-2681(19)32048-4 kostenfrei https://doaj.org/article/99846554ce38411d82f9b5ca1a08b5b8 kostenfrei http://www.sciencedirect.com/science/article/pii/S1665268119320484 kostenfrei https://doaj.org/toc/1665-2681 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 AR 4 2005 4 255-260 |
| allfields_unstemmed |
10.1016/S1665-2681(19)32048-4 doi (DE-627)DOAJ05293960X (DE-599)DOAJ99846554ce38411d82f9b5ca1a08b5b8 DE-627 ger DE-627 rakwb eng RC581-951 Norberto Sotelo verfasserin aut Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children with AI-CAH treated between 1978 and 2004 at the Hospital Infantil del Estado de Sonora in the Sonora State capital of Hermosillo in northern Mexico. Materials and methods: We conducted a retrospective review that included the following variables: age; sex; personal antecedents; signs and symptoms; laboratory and medical office studies; histologic tissue pattern obtained by biopsy; treatment; evolution, and mortality. Results: Thirteen males and 10 females participated in the study; predominant signs were hyporexia, fatigue-hepatomegalia, and icterus. Ten patients presented moderate anemia and six patients, leukopenia and thrombocytopenia. Eighteen patients presented hypergammaglobulinemia. Twenty three patients had percutaneous (p.c.) liver biopsy, and we observed the following histologic pattern: rupture of the limiting plate; necrotic foci; cholangiolar proliferation, and fibrotic bridges; in addition, four patients demonstrated precirrhotic changes. Twenty one children received prednisone for periods of between 1 and 12 years; in seven cases, children were administered azatioprine. Six children presented histologic, biochemical, and clinical remission, nine experienced biochemical remission but presented inflammatory activity, five abandoned treatment, and three died due to cirrhosis, liver insufficiency, and other complications. Discussion: To date, AI-CAH etiology continues to be unknown, while treatment has not been importantly modified in 50 years and continues to consist of prednisone alone or in association with azathioprine. Autoimmune hepatitis autoimmune-type chronic active hepatitis Specialties of internal medicine Guillermo López verfasserin aut In Annals of Hepatology Elsevier, 2021 4(2005), 4, Seite 255-260 (DE-627)DOAJ078617936 26595982 nnns volume:4 year:2005 number:4 pages:255-260 https://doi.org/10.1016/S1665-2681(19)32048-4 kostenfrei https://doaj.org/article/99846554ce38411d82f9b5ca1a08b5b8 kostenfrei http://www.sciencedirect.com/science/article/pii/S1665268119320484 kostenfrei https://doaj.org/toc/1665-2681 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 AR 4 2005 4 255-260 |
| allfieldsGer |
10.1016/S1665-2681(19)32048-4 doi (DE-627)DOAJ05293960X (DE-599)DOAJ99846554ce38411d82f9b5ca1a08b5b8 DE-627 ger DE-627 rakwb eng RC581-951 Norberto Sotelo verfasserin aut Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children with AI-CAH treated between 1978 and 2004 at the Hospital Infantil del Estado de Sonora in the Sonora State capital of Hermosillo in northern Mexico. Materials and methods: We conducted a retrospective review that included the following variables: age; sex; personal antecedents; signs and symptoms; laboratory and medical office studies; histologic tissue pattern obtained by biopsy; treatment; evolution, and mortality. Results: Thirteen males and 10 females participated in the study; predominant signs were hyporexia, fatigue-hepatomegalia, and icterus. Ten patients presented moderate anemia and six patients, leukopenia and thrombocytopenia. Eighteen patients presented hypergammaglobulinemia. Twenty three patients had percutaneous (p.c.) liver biopsy, and we observed the following histologic pattern: rupture of the limiting plate; necrotic foci; cholangiolar proliferation, and fibrotic bridges; in addition, four patients demonstrated precirrhotic changes. Twenty one children received prednisone for periods of between 1 and 12 years; in seven cases, children were administered azatioprine. Six children presented histologic, biochemical, and clinical remission, nine experienced biochemical remission but presented inflammatory activity, five abandoned treatment, and three died due to cirrhosis, liver insufficiency, and other complications. Discussion: To date, AI-CAH etiology continues to be unknown, while treatment has not been importantly modified in 50 years and continues to consist of prednisone alone or in association with azathioprine. Autoimmune hepatitis autoimmune-type chronic active hepatitis Specialties of internal medicine Guillermo López verfasserin aut In Annals of Hepatology Elsevier, 2021 4(2005), 4, Seite 255-260 (DE-627)DOAJ078617936 26595982 nnns volume:4 year:2005 number:4 pages:255-260 https://doi.org/10.1016/S1665-2681(19)32048-4 kostenfrei https://doaj.org/article/99846554ce38411d82f9b5ca1a08b5b8 kostenfrei http://www.sciencedirect.com/science/article/pii/S1665268119320484 kostenfrei https://doaj.org/toc/1665-2681 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 AR 4 2005 4 255-260 |
| allfieldsSound |
10.1016/S1665-2681(19)32048-4 doi (DE-627)DOAJ05293960X (DE-599)DOAJ99846554ce38411d82f9b5ca1a08b5b8 DE-627 ger DE-627 rakwb eng RC581-951 Norberto Sotelo verfasserin aut Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children with AI-CAH treated between 1978 and 2004 at the Hospital Infantil del Estado de Sonora in the Sonora State capital of Hermosillo in northern Mexico. Materials and methods: We conducted a retrospective review that included the following variables: age; sex; personal antecedents; signs and symptoms; laboratory and medical office studies; histologic tissue pattern obtained by biopsy; treatment; evolution, and mortality. Results: Thirteen males and 10 females participated in the study; predominant signs were hyporexia, fatigue-hepatomegalia, and icterus. Ten patients presented moderate anemia and six patients, leukopenia and thrombocytopenia. Eighteen patients presented hypergammaglobulinemia. Twenty three patients had percutaneous (p.c.) liver biopsy, and we observed the following histologic pattern: rupture of the limiting plate; necrotic foci; cholangiolar proliferation, and fibrotic bridges; in addition, four patients demonstrated precirrhotic changes. Twenty one children received prednisone for periods of between 1 and 12 years; in seven cases, children were administered azatioprine. Six children presented histologic, biochemical, and clinical remission, nine experienced biochemical remission but presented inflammatory activity, five abandoned treatment, and three died due to cirrhosis, liver insufficiency, and other complications. Discussion: To date, AI-CAH etiology continues to be unknown, while treatment has not been importantly modified in 50 years and continues to consist of prednisone alone or in association with azathioprine. Autoimmune hepatitis autoimmune-type chronic active hepatitis Specialties of internal medicine Guillermo López verfasserin aut In Annals of Hepatology Elsevier, 2021 4(2005), 4, Seite 255-260 (DE-627)DOAJ078617936 26595982 nnns volume:4 year:2005 number:4 pages:255-260 https://doi.org/10.1016/S1665-2681(19)32048-4 kostenfrei https://doaj.org/article/99846554ce38411d82f9b5ca1a08b5b8 kostenfrei http://www.sciencedirect.com/science/article/pii/S1665268119320484 kostenfrei https://doaj.org/toc/1665-2681 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 AR 4 2005 4 255-260 |
| language |
English |
| source |
In Annals of Hepatology 4(2005), 4, Seite 255-260 volume:4 year:2005 number:4 pages:255-260 |
| sourceStr |
In Annals of Hepatology 4(2005), 4, Seite 255-260 volume:4 year:2005 number:4 pages:255-260 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Autoimmune hepatitis autoimmune-type chronic active hepatitis Specialties of internal medicine |
| isfreeaccess_bool |
true |
| container_title |
Annals of Hepatology |
| authorswithroles_txt_mv |
Norberto Sotelo @@aut@@ Guillermo López @@aut@@ |
| publishDateDaySort_date |
2005-01-01T00:00:00Z |
| hierarchy_top_id |
DOAJ078617936 |
| id |
DOAJ05293960X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ05293960X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308171617.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2005 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1665-2681(19)32048-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ05293960X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ99846554ce38411d82f9b5ca1a08b5b8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC581-951</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Norberto Sotelo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children with AI-CAH treated between 1978 and 2004 at the Hospital Infantil del Estado de Sonora in the Sonora State capital of Hermosillo in northern Mexico. Materials and methods: We conducted a retrospective review that included the following variables: age; sex; personal antecedents; signs and symptoms; laboratory and medical office studies; histologic tissue pattern obtained by biopsy; treatment; evolution, and mortality. Results: Thirteen males and 10 females participated in the study; predominant signs were hyporexia, fatigue-hepatomegalia, and icterus. Ten patients presented moderate anemia and six patients, leukopenia and thrombocytopenia. Eighteen patients presented hypergammaglobulinemia. Twenty three patients had percutaneous (p.c.) liver biopsy, and we observed the following histologic pattern: rupture of the limiting plate; necrotic foci; cholangiolar proliferation, and fibrotic bridges; in addition, four patients demonstrated precirrhotic changes. Twenty one children received prednisone for periods of between 1 and 12 years; in seven cases, children were administered azatioprine. Six children presented histologic, biochemical, and clinical remission, nine experienced biochemical remission but presented inflammatory activity, five abandoned treatment, and three died due to cirrhosis, liver insufficiency, and other complications. Discussion: To date, AI-CAH etiology continues to be unknown, while treatment has not been importantly modified in 50 years and continues to consist of prednisone alone or in association with azathioprine.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Autoimmune hepatitis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">autoimmune-type chronic active hepatitis</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Specialties of internal medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Guillermo López</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Annals of Hepatology</subfield><subfield code="d">Elsevier, 2021</subfield><subfield code="g">4(2005), 4, Seite 255-260</subfield><subfield code="w">(DE-627)DOAJ078617936</subfield><subfield code="x">26595982</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:255-260</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1665-2681(19)32048-4</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/99846554ce38411d82f9b5ca1a08b5b8</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S1665268119320484</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1665-2681</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2002</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">2005</subfield><subfield code="e">4</subfield><subfield code="h">255-260</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
Norberto Sotelo |
| spellingShingle |
Norberto Sotelo misc RC581-951 misc Autoimmune hepatitis misc autoimmune-type chronic active hepatitis misc Specialties of internal medicine Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico |
| authorStr |
Norberto Sotelo |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)DOAJ078617936 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
RC581-951 |
| illustrated |
Not Illustrated |
| issn |
26595982 |
| topic_title |
RC581-951 Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico Autoimmune hepatitis autoimmune-type chronic active hepatitis |
| topic |
misc RC581-951 misc Autoimmune hepatitis misc autoimmune-type chronic active hepatitis misc Specialties of internal medicine |
| topic_unstemmed |
misc RC581-951 misc Autoimmune hepatitis misc autoimmune-type chronic active hepatitis misc Specialties of internal medicine |
| topic_browse |
misc RC581-951 misc Autoimmune hepatitis misc autoimmune-type chronic active hepatitis misc Specialties of internal medicine |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Annals of Hepatology |
| hierarchy_parent_id |
DOAJ078617936 |
| hierarchy_top_title |
Annals of Hepatology |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)DOAJ078617936 |
| title |
Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico |
| ctrlnum |
(DE-627)DOAJ05293960X (DE-599)DOAJ99846554ce38411d82f9b5ca1a08b5b8 |
| title_full |
Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico |
| author_sort |
Norberto Sotelo |
| journal |
Annals of Hepatology |
| journalStr |
Annals of Hepatology |
| callnumber-first-code |
R |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2005 |
| contenttype_str_mv |
txt |
| container_start_page |
255 |
| author_browse |
Norberto Sotelo Guillermo López |
| container_volume |
4 |
| class |
RC581-951 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Norberto Sotelo |
| doi_str_mv |
10.1016/S1665-2681(19)32048-4 |
| author2-role |
verfasserin |
| title_sort |
autoimmune-type chronic active hepatitis in children. a report of 23 cases at a hospital in northwestern mexico |
| callnumber |
RC581-951 |
| title_auth |
Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico |
| abstract |
Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children with AI-CAH treated between 1978 and 2004 at the Hospital Infantil del Estado de Sonora in the Sonora State capital of Hermosillo in northern Mexico. Materials and methods: We conducted a retrospective review that included the following variables: age; sex; personal antecedents; signs and symptoms; laboratory and medical office studies; histologic tissue pattern obtained by biopsy; treatment; evolution, and mortality. Results: Thirteen males and 10 females participated in the study; predominant signs were hyporexia, fatigue-hepatomegalia, and icterus. Ten patients presented moderate anemia and six patients, leukopenia and thrombocytopenia. Eighteen patients presented hypergammaglobulinemia. Twenty three patients had percutaneous (p.c.) liver biopsy, and we observed the following histologic pattern: rupture of the limiting plate; necrotic foci; cholangiolar proliferation, and fibrotic bridges; in addition, four patients demonstrated precirrhotic changes. Twenty one children received prednisone for periods of between 1 and 12 years; in seven cases, children were administered azatioprine. Six children presented histologic, biochemical, and clinical remission, nine experienced biochemical remission but presented inflammatory activity, five abandoned treatment, and three died due to cirrhosis, liver insufficiency, and other complications. Discussion: To date, AI-CAH etiology continues to be unknown, while treatment has not been importantly modified in 50 years and continues to consist of prednisone alone or in association with azathioprine. |
| abstractGer |
Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children with AI-CAH treated between 1978 and 2004 at the Hospital Infantil del Estado de Sonora in the Sonora State capital of Hermosillo in northern Mexico. Materials and methods: We conducted a retrospective review that included the following variables: age; sex; personal antecedents; signs and symptoms; laboratory and medical office studies; histologic tissue pattern obtained by biopsy; treatment; evolution, and mortality. Results: Thirteen males and 10 females participated in the study; predominant signs were hyporexia, fatigue-hepatomegalia, and icterus. Ten patients presented moderate anemia and six patients, leukopenia and thrombocytopenia. Eighteen patients presented hypergammaglobulinemia. Twenty three patients had percutaneous (p.c.) liver biopsy, and we observed the following histologic pattern: rupture of the limiting plate; necrotic foci; cholangiolar proliferation, and fibrotic bridges; in addition, four patients demonstrated precirrhotic changes. Twenty one children received prednisone for periods of between 1 and 12 years; in seven cases, children were administered azatioprine. Six children presented histologic, biochemical, and clinical remission, nine experienced biochemical remission but presented inflammatory activity, five abandoned treatment, and three died due to cirrhosis, liver insufficiency, and other complications. Discussion: To date, AI-CAH etiology continues to be unknown, while treatment has not been importantly modified in 50 years and continues to consist of prednisone alone or in association with azathioprine. |
| abstract_unstemmed |
Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children with AI-CAH treated between 1978 and 2004 at the Hospital Infantil del Estado de Sonora in the Sonora State capital of Hermosillo in northern Mexico. Materials and methods: We conducted a retrospective review that included the following variables: age; sex; personal antecedents; signs and symptoms; laboratory and medical office studies; histologic tissue pattern obtained by biopsy; treatment; evolution, and mortality. Results: Thirteen males and 10 females participated in the study; predominant signs were hyporexia, fatigue-hepatomegalia, and icterus. Ten patients presented moderate anemia and six patients, leukopenia and thrombocytopenia. Eighteen patients presented hypergammaglobulinemia. Twenty three patients had percutaneous (p.c.) liver biopsy, and we observed the following histologic pattern: rupture of the limiting plate; necrotic foci; cholangiolar proliferation, and fibrotic bridges; in addition, four patients demonstrated precirrhotic changes. Twenty one children received prednisone for periods of between 1 and 12 years; in seven cases, children were administered azatioprine. Six children presented histologic, biochemical, and clinical remission, nine experienced biochemical remission but presented inflammatory activity, five abandoned treatment, and three died due to cirrhosis, liver insufficiency, and other complications. Discussion: To date, AI-CAH etiology continues to be unknown, while treatment has not been importantly modified in 50 years and continues to consist of prednisone alone or in association with azathioprine. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 |
| container_issue |
4 |
| title_short |
Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico |
| url |
https://doi.org/10.1016/S1665-2681(19)32048-4 https://doaj.org/article/99846554ce38411d82f9b5ca1a08b5b8 http://www.sciencedirect.com/science/article/pii/S1665268119320484 https://doaj.org/toc/1665-2681 |
| remote_bool |
true |
| author2 |
Guillermo López |
| author2Str |
Guillermo López |
| ppnlink |
DOAJ078617936 |
| callnumber-subject |
RC - Internal Medicine |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.1016/S1665-2681(19)32048-4 |
| callnumber-a |
RC581-951 |
| up_date |
2024-07-03T14:54:21.696Z |
| _version_ |
1803570078497636352 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ05293960X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308171617.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2005 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1665-2681(19)32048-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ05293960X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ99846554ce38411d82f9b5ca1a08b5b8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC581-951</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Norberto Sotelo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Autoimmune-type chronic active hepatitis in children. A report of 23 cases at a Hospital in Northwestern Mexico</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction: Autoimmune type chronic active hepatitis (AI-CAH) is a rare pediatric disorder whose principal characteristics include hepatocellular dysfunction and active tissue damage with evolution to cirrhosis in 25-30% of cases. Objective: Our aim was to ascertain the evolution of 23 children with AI-CAH treated between 1978 and 2004 at the Hospital Infantil del Estado de Sonora in the Sonora State capital of Hermosillo in northern Mexico. Materials and methods: We conducted a retrospective review that included the following variables: age; sex; personal antecedents; signs and symptoms; laboratory and medical office studies; histologic tissue pattern obtained by biopsy; treatment; evolution, and mortality. Results: Thirteen males and 10 females participated in the study; predominant signs were hyporexia, fatigue-hepatomegalia, and icterus. Ten patients presented moderate anemia and six patients, leukopenia and thrombocytopenia. Eighteen patients presented hypergammaglobulinemia. Twenty three patients had percutaneous (p.c.) liver biopsy, and we observed the following histologic pattern: rupture of the limiting plate; necrotic foci; cholangiolar proliferation, and fibrotic bridges; in addition, four patients demonstrated precirrhotic changes. Twenty one children received prednisone for periods of between 1 and 12 years; in seven cases, children were administered azatioprine. Six children presented histologic, biochemical, and clinical remission, nine experienced biochemical remission but presented inflammatory activity, five abandoned treatment, and three died due to cirrhosis, liver insufficiency, and other complications. Discussion: To date, AI-CAH etiology continues to be unknown, while treatment has not been importantly modified in 50 years and continues to consist of prednisone alone or in association with azathioprine.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Autoimmune hepatitis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">autoimmune-type chronic active hepatitis</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Specialties of internal medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Guillermo López</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Annals of Hepatology</subfield><subfield code="d">Elsevier, 2021</subfield><subfield code="g">4(2005), 4, Seite 255-260</subfield><subfield code="w">(DE-627)DOAJ078617936</subfield><subfield code="x">26595982</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:255-260</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1665-2681(19)32048-4</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/99846554ce38411d82f9b5ca1a08b5b8</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S1665268119320484</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1665-2681</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2002</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">2005</subfield><subfield code="e">4</subfield><subfield code="h">255-260</subfield></datafield></record></collection>
|
| score |
7.397312 |